mechanisms of resistance to car-t therapy in lymphoma & potential strategies to overcome these
Published 1 year ago • 217 plays • Length 2:43Download video MP4
Download video MP3
Similar videos
-
2:10
mechanisms of resistance to car t-cells in myeloma & future considerations
-
1:35
key mechanisms of resistance to car t-cell therapy
-
3:38
mechanisms of resistance to car-t in all: t-cell fitness, antigen loss and immunological rejection
-
3:14
car t-cell therapy explained (manufacturing process & how it works)
-
3:12
an insight into resistance mechanisms of cll cells to car-t therapy
-
11:18
car-t cells: engineered cancer killers
-
2:20
novel car-t products in the pipeline for multiple myeloma
-
2:21
car t-cell therapy: how does it work?
-
1:18
the importance of lymphodepletion, an undervalued component of the car-t therapy cycle
-
2:43
resistance to car t-cell therapy
-
1:59
investigating the mechanisms of initial & acquired resistance to bcma car-t therapy in myeloma
-
2:38
car-t therapy for aggressive b-cell lymphomas
-
5:09
mechanisms of resistance to car t-cell therapies
-
3:57
mechanisms and management of short- and long-term car-t toxicities
-
1:25
the role of car-t therapy and hsct in autoimmune disorders
-
1:38
challenges of car-t therapy in the real-world setting
-
3:21
practical considerations for car-t therapy in lymphoma
-
3:33
an overview of the car t-cell therapy story
-
0:45
car-t resistance in tp53-mutated b-all: a loss of signalling
-
0:37
the mechanism of treatment resistance in aml: do cd8-expressing t-cells become exhausted?
-
3:31
the role of lymphodepletion in car t-cell therapy: current knowledge & the need for personalization
-
5:43
strategies to overcome the current obstacles in car-t manufacturing